Over-the-Counter Medicines
Piroxica Gel
- Product Category
- Analgesic, anti-inflammatory, astringent, anti-inflammatory
- Active Ingredients
- piroxicam
- Appearance
- Light yellow transparent gel
01 / 01
1. Composition and Strength
- Active ingredients (out of 1g):
Piroxicam (KP) ······ 5mg
- Additives: Ethanol, purified water, Carbomer 940, Trolamine, Polysorbate 60, propylene glycol, D-sorbitol liquid, l-menthol
2. Effectiveness
Analgesic/anti-inflammatory (anti-inflammatory) for the following diseases and symptoms: degenerative arthritis (osteoarthritis), periarthritis of the shoulder, tendinitis (tendinitis), tenosynovitis (tenosynovitis), peritendinitis, epicondylitis of the humerus (tennis elbow, etc.), muscle pain (myositis, fasciitis, etc.), swelling and pain (pain) after trauma.
3. Dosage and dosage
Adults, apply 1g (approximately 3cm) once, to the affected area (disease area) 3-4 times a day and rub lightly to allow it to penetrate well.
4. Precautions for use
1. Do not administer to the following patients:
1) Patients with a history of hypersensitivity to this drug or other piroxicam preparations
2) Patients with aspirin asthma (an asthma attack caused by non-steroidal anti-inflammatory drugs, etc.) or a history of it (can cause a severe asthma attack).
3) Patients who developed urticaria, rhinitis, and angioedema (vascular swelling, angioedema) due to aspirin or other non-steroidal anti-inflammatory drugs.
4) Children under 14 years of age
2. Administer with caution to the following patients.
1) Patients with bronchial asthma (can cause severe asthma attack)
2) This medicine contains propylene glycol, so administer it with caution to patients who are hypersensitive to this ingredient or have a history of allergy.
3. Adverse reactions
1) Skin: Occasionally, local itching, redness, rash, scales, eczema/dermatitis, contact dermatitis, erythema (red spots), and rarely photosensitivity may occur. If these symptoms are severe, discontinue use.
2) In case of long-term or excessive administration, systemic adverse reactions may include nausea, gastrointestinal discomfort, dyspnea, renal failure, and acute interstitial nephritis (nephritis) in patients with nephrotic syndrome.
4. Generalism
1) Please note that treatment with anti-inflammatory painkillers is symptomatic treatment, not causative treatment.
2) Since it can make skin infections invisible (so that they do not appear on the surface), when using it for inflammation accompanying infection, use it in combination with an appropriate antibacterial or antifungal agent (take it together) and administer carefully after sufficient observation.
3) When used for chronic diseases (degenerative arthritis (osteoarthritis), etc.), treatments other than drug therapy should also be considered. Also, carefully observe the patient's condition and pay attention to the occurrence of adverse reactions.
5. Administration to pregnant and lactating women
1) 3rd trimester of pregnancy: Inhibition of prostaglandin synthesis may delay childbirth and cause blood loss during birth, neonatal hemorrhage, fetal cardiopulmonary toxicity (pulmonary hypertension accompanying premature closure of the ductus arteriosus), and renal failure accompanied by oligohydramnios due to decreased renal function, so it should not be used in pregnant women during this period.
2) 1st and 2nd trimester of pregnancy: As a result of animal reproduction experiments, no fetal toxicity occurred, but no studies on pregnant women have been found yet.
3) After oral administration (eating, taking) of piroxicam, approximately 1% of the blood concentration was found in breast milk. The concentration of the active ingredient in breast milk and its clinical relevance have not yet been determined, but it is not administered to nursing mothers.
6. Administration to children
Safety for premature infants, newborns, infants (nursing, newborns), infants, and children has not been established.
7. Administration to elderly people
For elderly people, be especially careful about the occurrence of adverse reactions and administer with caution, limiting administration to the minimum necessary.
8. Application precautions
1) Do not use on skin with lesions (changes in the body due to disease) (hemorrhagic skin disease, eczema, infected lesions (changes in the body due to disease), burns, wounds), eyes, or mucous membranes.
2) Do not use as a sealed bandage method.
3) Be careful when using if your skin is damaged as it may cause temporary irritation.
5. How to save
Airtight container, stored at room temperature (1~30℃)
6. Packaging unit
70 grams/tube
7. Period of use
36 months from date of manufacture
- Active ingredients (out of 1g):
Piroxicam (KP) ······ 5mg
- Additives: Ethanol, purified water, Carbomer 940, Trolamine, Polysorbate 60, propylene glycol, D-sorbitol liquid, l-menthol
2. Effectiveness
Analgesic/anti-inflammatory (anti-inflammatory) for the following diseases and symptoms: degenerative arthritis (osteoarthritis), periarthritis of the shoulder, tendinitis (tendinitis), tenosynovitis (tenosynovitis), peritendinitis, epicondylitis of the humerus (tennis elbow, etc.), muscle pain (myositis, fasciitis, etc.), swelling and pain (pain) after trauma.
3. Dosage and dosage
Adults, apply 1g (approximately 3cm) once, to the affected area (disease area) 3-4 times a day and rub lightly to allow it to penetrate well.
4. Precautions for use
1. Do not administer to the following patients:
1) Patients with a history of hypersensitivity to this drug or other piroxicam preparations
2) Patients with aspirin asthma (an asthma attack caused by non-steroidal anti-inflammatory drugs, etc.) or a history of it (can cause a severe asthma attack).
3) Patients who developed urticaria, rhinitis, and angioedema (vascular swelling, angioedema) due to aspirin or other non-steroidal anti-inflammatory drugs.
4) Children under 14 years of age
2. Administer with caution to the following patients.
1) Patients with bronchial asthma (can cause severe asthma attack)
2) This medicine contains propylene glycol, so administer it with caution to patients who are hypersensitive to this ingredient or have a history of allergy.
3. Adverse reactions
1) Skin: Occasionally, local itching, redness, rash, scales, eczema/dermatitis, contact dermatitis, erythema (red spots), and rarely photosensitivity may occur. If these symptoms are severe, discontinue use.
2) In case of long-term or excessive administration, systemic adverse reactions may include nausea, gastrointestinal discomfort, dyspnea, renal failure, and acute interstitial nephritis (nephritis) in patients with nephrotic syndrome.
4. Generalism
1) Please note that treatment with anti-inflammatory painkillers is symptomatic treatment, not causative treatment.
2) Since it can make skin infections invisible (so that they do not appear on the surface), when using it for inflammation accompanying infection, use it in combination with an appropriate antibacterial or antifungal agent (take it together) and administer carefully after sufficient observation.
3) When used for chronic diseases (degenerative arthritis (osteoarthritis), etc.), treatments other than drug therapy should also be considered. Also, carefully observe the patient's condition and pay attention to the occurrence of adverse reactions.
5. Administration to pregnant and lactating women
1) 3rd trimester of pregnancy: Inhibition of prostaglandin synthesis may delay childbirth and cause blood loss during birth, neonatal hemorrhage, fetal cardiopulmonary toxicity (pulmonary hypertension accompanying premature closure of the ductus arteriosus), and renal failure accompanied by oligohydramnios due to decreased renal function, so it should not be used in pregnant women during this period.
2) 1st and 2nd trimester of pregnancy: As a result of animal reproduction experiments, no fetal toxicity occurred, but no studies on pregnant women have been found yet.
3) After oral administration (eating, taking) of piroxicam, approximately 1% of the blood concentration was found in breast milk. The concentration of the active ingredient in breast milk and its clinical relevance have not yet been determined, but it is not administered to nursing mothers.
6. Administration to children
Safety for premature infants, newborns, infants (nursing, newborns), infants, and children has not been established.
7. Administration to elderly people
For elderly people, be especially careful about the occurrence of adverse reactions and administer with caution, limiting administration to the minimum necessary.
8. Application precautions
1) Do not use on skin with lesions (changes in the body due to disease) (hemorrhagic skin disease, eczema, infected lesions (changes in the body due to disease), burns, wounds), eyes, or mucous membranes.
2) Do not use as a sealed bandage method.
3) Be careful when using if your skin is damaged as it may cause temporary irritation.
5. How to save
Airtight container, stored at room temperature (1~30℃)
6. Packaging unit
70 grams/tube
7. Period of use
36 months from date of manufacture